Cogent Biosciences CEO and Key Executive Team

• Andrew Robbins

  Chief Executive Officer and President
• John Green

  Chief Financial Officer
• Brad Barnett

  Chief Technology Officer
• John Robinson

  Chief Scientific Officer
• Jessica Sachs

  Chief Medical Officer
• Evan Kearns

  Chief Legal Officer and Corporate Secretary
• Erin Schellhammer

  Chief People Officer
• Peter Harwin

  Director
• Chris Cain

  Director
• Dana Martin

  Senior Vice President, Medical Affairs
• Karen Ferrante

  Director
• Arlene M. Morris

  Director
• Matthew E. Ros

  Director
• Todd E. Shegog

  Director
• Francis Sullivan

  Vice President, Enzymology and Structural Biology
• Shannon Winski

  Vice President, Pharmacology and Toxicology
• Brad Fell

  Senior Vice President, Chemistry
• Rachel Easton

  Vice President, Clinical Development
• Ben Exter

  Senior Vice President, Head of Regulatory and Pharmacovigilance
• Mark Lohman

  Vice President, Program Leader
• Lei Sun

  Vice President, Clinical Pharmacology and Translational Medicine
• Courtney Watson

  Senior Vice President, Head of Clinical Development Operations

Source: cogentbio.com, unumrx.com, cogentbio.com